
EU Commission fines Teva $500 million for trying to stop rival’s multiple sclerosis drug
BRUSSELS (AP) — The European Commission has fined Israeli generic drugmaker Teva more than 460 million euros ($500 million) for improperly seeking…
Continue Reading